Ajila V and others, ‘Human Papilloma Virus Associated Squamous Cell Carcinoma of the Head and Neck’ (2015) 2015 Journal of Sexually Transmitted Diseases 1
Barrett DM, Grupp SA and June CH, ‘Chimeric Antigen Receptor– and TCR-Modified T Cells Enter Main Street and Wall Street’ (2015) 195 The Journal of Immunology 755
de Martel C and others, ‘Global Burden of Cancers Attributable to Infections in 2008: A Review and Synthetic Analysis’ (2012) 13 The Lancet Oncology 607
Ecker DM, Jones SD and Levine HL, ‘The Therapeutic Monoclonal Antibody Market’ (2015) 7 mAbs 9
Gill S and June CH, ‘Going Viral: Chimeric Antigen Receptor T-Cell Therapy for Hematological Malignancies’ (2015) 263 Immunological Reviews 68
Grupp SA and others, ‘Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia’ (2013) 368 New England Journal of Medicine 1509
Hanahan D and Weinberg RA, ‘The Hallmarks of Cancer’ (2000) 100 Cell 57
Hodi FS and others, ‘Improved Survival with Ipilimumab in Patients with Metastatic Melanoma’ (2010) 363 New England Journal of Medicine 711
Jeggo PA, Pearl LH and Carr AM, ‘DNA Repair, Genome Stability and Cancer: A Historical Perspective’ (2015) 16 Nature Reviews Cancer 35
Kaufman HL, Kohlhapp FJ and Zloza A, ‘Oncolytic Viruses: A New Class of Immunotherapy Drugs’ (2015) 14 Nature Reviews Drug Discovery 642
Klebanoff CA, Rosenberg SA and Restifo NP, ‘Prospects for Gene-Engineered T Cell Immunotherapy for Solid Cancers’ (2016) 22 Nature Medicine 26
Koebel CM and others, ‘Adaptive Immunity Maintains Occult Cancer in an Equilibrium State’ (2007) 450 Nature 903
Larson C and others, ‘Going Viral: A Review of Replication-Selective Oncolytic Adenoviruses’ (2015) 6 Oncotarget
Lazebnik Y, ‘What Are the Hallmarks of Cancer?’ (2010) 10 Nature Reviews Cancer 232
Lingyun Geng, ‘Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Experimental and Clinical Developments’ (2015) 8 International Journal of Clinical and Experimental Medicine <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658837/>
Matsuoka M and Jeang K-T, ‘Human T-Cell Leukemia Virus Type 1 (HTLV-1) and Leukemic Transformation: Viral Infectivity, Tax, HBZ and Therapy’ (2011) 30 Oncogene 1379
Morris EC and Stauss HJ, ‘Optimizing T-Cell Receptor Gene Therapy for Hematologic Malignancies’ (2016) 127 Blood 3305
Palucka K and Banchereau J, ‘Cancer Immunotherapy via Dendritic Cells’ (2012) 12 Nature Reviews Cancer 265
Pierangeli A, Antonelli G and Gentile G, ‘Immunodeficiency-Associated Viral Oncogenesis’ (2015) 21 Clinical Microbiology and Infection 975
Reichert JM, ‘Marketed Therapeutic Antibodies Compendium’ (2012) 4 mAbs 413
——, ‘Antibodies to Watch in 2016’ (2016) 8 mAbs 197
——, ‘Antibodies to Watch in 2017’ (2017) 9 mAbs 167
Restifo NP, Dudley ME and Rosenberg SA, ‘Adoptive Immunotherapy for Cancer: Harnessing the T Cell Response’ (2012) 12 Nature Reviews Immunology 269
Robbins PF and others, ‘Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1’ (2011) 29 Journal of Clinical Oncology 917
Robert D. Schreiber, Lloyd J. Old and Mark J. Smyth, ‘Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion’ (2011) 331 Science 1565 <http://www.jstor.org/stable/29783923?seq=1#page_scan_tab_contents>
Roos WP, Thomas AD and Kaina B, ‘DNA Damage and the Balance between Survival and Death in Cancer Biology’ (2015) 16 Nature Reviews Cancer 20
Russell SJ, Peng K-W and Bell JC, ‘Oncolytic Virotherapy’ (2012) 30 Nature Biotechnology 658
Schinzari V, Barnaba V and Piconese S, ‘Chronic Hepatitis B Virus and Hepatitis C Virus Infections and Cancer: Synergy between Viral and Host Factors’ (2015) 21 Clinical Microbiology and Infection 969
Schumacher TN and Schreiber RD, ‘Neoantigens in Cancer Immunotherapy’ (2015) 348 Science 69
Shankaran V and others, ‘IFNγ and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity’ (2001) 410 Nature 1107
Spurgeon ME and Lambert PF, ‘Merkel Cell Polyomavirus: A Newly Discovered Human Virus with Oncogenic Potential’ (2013) 435 Virology 118
Topalian SL and others, ‘Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer’ (2012) 366 New England Journal of Medicine 2443
Varghese S and Rabkin SD, ‘Oncolytic Herpes Simplex Virus Vectors for Cancer Virotherapy’ (2002) 9 Cancer Gene Therapy 967
Weinberg RA, The Biology of Cancer (2nd ed, Garland Science 2014)
Weiss RA and Vogt PK, ‘100 Years of Rous Sarcoma Virus’ (2011) 208 The Journal of Experimental Medicine 2351
Wendzicki JA, Moore PS and Chang Y, ‘Large T and Small T Antigens of Merkel Cell Polyomavirus’ (2015) 11 Current Opinion in Virology 38
zur Hausen H, ‘Papillomaviruses in the Causation of Human Cancers — a Brief Historical Account’ (2009) 384 Virology 260
